Published in Lancet Neurol on November 01, 2006
Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2007) 22.53
Pathway-based approaches for analysis of genomewide association studies. Am J Hum Genet (2007) 12.27
Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet (2009) 10.34
Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet (2011) 9.10
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet (2009) 8.11
Discerning the ancestry of European Americans in genetic association studies. PLoS Genet (2007) 7.81
Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum Genet (2008) 5.04
Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. PLoS Genet (2011) 5.01
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet (2010) 4.47
Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet (2012) 4.27
Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet (2010) 4.26
VPS35 mutations in Parkinson disease. Am J Hum Genet (2011) 4.16
Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat Genet (2009) 3.52
A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet (2007) 3.28
Highly cost-efficient genome-wide association studies using DNA pools and dense SNP arrays. Nucleic Acids Res (2008) 3.08
A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release. Lancet Neurol (2007) 2.99
Imputation of missing genotypes: an empirical evaluation of IMPUTE. BMC Genet (2008) 2.34
Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. Ann Neurol (2012) 2.20
Extent of genome-wide linkage disequilibrium in Australian Holstein-Friesian cattle based on a high-density SNP panel. BMC Genomics (2008) 2.16
Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model. Proc Natl Acad Sci U S A (2008) 2.09
Genomic investigation of alpha-synuclein multiplication and parkinsonism. Ann Neurol (2008) 2.04
A random forest approach to the detection of epistatic interactions in case-control studies. BMC Bioinformatics (2009) 2.03
Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. Lancet Neurol (2006) 1.92
Meta-analysis in genome-wide association datasets: strategies and application in Parkinson disease. PLoS One (2007) 1.69
Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease. Hum Mol Genet (2012) 1.68
A method for detecting epistasis in genome-wide studies using case-control multi-locus association analysis. BMC Genomics (2008) 1.64
The genetics of Parkinson's disease: progress and therapeutic implications. Mov Disord (2013) 1.63
Enhancing genetic mapping of complex genomes through the design of highly-multiplexed SNP arrays: application to the large and unsequenced genomes of white spruce and black spruce. BMC Genomics (2008) 1.57
Tracing sub-structure in the European American population with PCA-informative markers. PLoS Genet (2008) 1.56
The genetics and neuropathology of Parkinson's disease. Acta Neuropathol (2012) 1.56
SNCA variant associated with Parkinson disease and plasma alpha-synuclein level. Arch Neurol (2010) 1.54
Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population. BMC Med Genet (2011) 1.36
Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis. Biochim Biophys Acta (2008) 1.35
Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson's disease. J Neurol (2009) 1.27
TDP-43 is not a common cause of sporadic amyotrophic lateral sclerosis. PLoS One (2008) 1.27
Detection, imputation, and association analysis of small deletions and null alleles on oligonucleotide arrays. Am J Hum Genet (2008) 1.27
Axon guidance and synaptic maintenance: preclinical markers for neurodegenerative disease and therapeutics. Trends Neurosci (2009) 1.24
Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms. Am J Hum Genet (2007) 1.24
Genomewide association study for onset age in Parkinson disease. BMC Med Genet (2009) 1.24
LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease. Mov Disord (2009) 1.22
Convergence of miRNA expression profiling, α-synuclein interacton and GWAS in Parkinson's disease. PLoS One (2011) 1.19
LINGO1 rs9652490 is associated with essential tremor and Parkinson disease. Parkinsonism Relat Disord (2009) 1.18
Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease. PLoS One (2010) 1.18
Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study. PLoS Med (2013) 1.18
Epistatic module detection for case-control studies: a Bayesian model with a Gibbs sampling strategy. PLoS Genet (2009) 1.17
An entropy test for single-locus genetic association analysis. BMC Genet (2010) 1.15
Beyond Parkinson disease: amyotrophic lateral sclerosis and the axon guidance pathway. PLoS One (2008) 1.13
PADB: published association database. BMC Bioinformatics (2007) 1.12
A novel haplotype-sharing approach for genome-wide case-control association studies implicates the calpastatin gene in Parkinson's disease. Genet Epidemiol (2009) 1.10
Allelic association studies of genome wide association data can reveal errors in marker position assignments. BMC Genet (2007) 1.09
The heritability of risk and age at onset of Parkinson's disease after accounting for known genetic risk factors. J Hum Genet (2010) 1.09
Genome-wide autozygosity mapping in human populations. Genet Epidemiol (2009) 1.07
A Bayesian approach to efficient differential allocation for resampling-based significance testing. BMC Bioinformatics (2009) 1.07
Whole genome survey of coding SNPs reveals a reproducible pathway determinant of Parkinson disease. Hum Mutat (2009) 1.06
Genetics and genomics of Parkinson's disease. Genome Med (2014) 1.04
A simple method for assessing the strength of evidence for association at the level of the whole gene. Adv Appl Bioinform Chem (2008) 1.04
Replication of GWAS associations for GAK and MAPT in Parkinson's disease. Ann Hum Genet (2010) 1.03
GWAS risk factors in Parkinson's disease: LRRK2 coding variation and genetic interaction with PARK16. Am J Neurodegener Dis (2013) 1.03
Identifying consensus disease pathways in Parkinson's disease using an integrative systems biology approach. PLoS One (2011) 1.02
ATP13A2 (PARK9) polymorphisms influence the neurotoxic effects of manganese. Neurotoxicology (2012) 1.02
Detecting disease-associated genotype patterns. BMC Bioinformatics (2009) 1.01
Genome-wide association studies in neurological disorders. Lancet Neurol (2008) 1.01
Two-stage association study and meta-analysis of mitochondrial DNA variants in Parkinson disease. Neurology (2013) 1.00
MegaSNPHunter: a learning approach to detect disease predisposition SNPs and high level interactions in genome wide association study. BMC Bioinformatics (2009) 1.00
Non-replication of association for six polymorphisms from meta-analysis of genome-wide association studies of Parkinson's disease: large-scale collaborative study. Am J Med Genet B Neuropsychiatr Genet (2010) 0.99
Neither replication nor simulation supports a role for the axon guidance pathway in the genetics of Parkinson's disease. PLoS One (2008) 0.99
Combining identity by descent and association in genetic case-control studies. BMC Genet (2008) 0.99
Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus. Neurology (2010) 0.99
Bayesian semiparametric multiple shrinkage. Biometrics (2009) 0.98
Genetics of Parkinson disease and essential tremor. Curr Opin Neurol (2010) 0.96
A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease. Neurobiol Aging (2009) 0.95
Association of alpha-, beta-, and gamma-Synuclein with diffuse lewy body disease. Arch Neurol (2010) 0.95
Structural genomic variation in ischemic stroke. Neurogenetics (2008) 0.93
A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease. Hum Mol Genet (2012) 0.93
Polygenic risk of Parkinson disease is correlated with disease age at onset. Ann Neurol (2015) 0.92
A unified framework for multi-locus association analysis of both common and rare variants. BMC Genomics (2011) 0.92
Evidence for a common pathway linking neurodegenerative diseases. Nat Genet (2009) 0.92
CoAIMs: a cost-effective panel of ancestry informative markers for determining continental origins. PLoS One (2010) 0.91
Cyclin-G-associated kinase modifies α-synuclein expression levels and toxicity in Parkinson's disease: results from the GenePD Study. Hum Mol Genet (2011) 0.91
Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance. J Neurochem (2016) 0.91
Common variants in PARK loci and related genes and Parkinson's disease. Mov Disord (2010) 0.90
Coffee, caffeine-related genes, and Parkinson's disease: a case-control study. Mov Disord (2008) 0.89
Genomic convergence and network analysis approach to identify candidate genes in Alzheimer's disease. BMC Genomics (2014) 0.88
The effects of chronic treatment with mood stabilizers on the rat hippocampal post-synaptic density proteome. J Neurochem (2011) 0.88
Evaluation of Parkinson disease risk variants as expression-QTLs. PLoS One (2012) 0.88
Genetic association study between STK39 and CCDC62/HIP1R and Parkinson's disease. PLoS One (2013) 0.87
Phactr2 and Parkinson's disease. Neurosci Lett (2009) 0.87
Parkinson's disease and low frequency alleles found together throughout LRRK2. Ann Hum Genet (2009) 0.86
Premotor biomarkers for Parkinson's disease - a promising direction of research. Transl Neurodegener (2012) 0.86
Efficient whole-genome association mapping using local phylogenies for unphased genotype data. Bioinformatics (2008) 0.85
Beta-synuclein gene variants and Parkinson's disease: a preliminary case-control study. Neurosci Lett (2007) 0.85
A survey on computer aided diagnosis for ocular diseases. BMC Med Inform Decis Mak (2014) 0.85
Genetic variability in SNCA and Parkinson's disease. Neurogenetics (2011) 0.85
A predictable worm: application of Caenorhabditis elegans for mechanistic investigation of movement disorders. Neurotherapeutics (2012) 0.84
Amyotrophic lateral sclerosis: an emerging era of collaborative gene discovery. PLoS One (2007) 0.83
Efficient and biologically relevant consensus strategy for Parkinson's disease gene prioritization. BMC Med Genomics (2016) 0.83
Genetic analysis of heme oxygenase-1 (HO-1) in German Parkinson's disease patients. J Neural Transm (Vienna) (2009) 0.83
A genome-wide linkage screen in the Amish with Parkinson disease points to chromosome 6. Ann Hum Genet (2011) 0.83
Genetic variation in FGF20 modulates hippocampal biology. J Neurosci (2010) 0.83
Genome-wide association data classification and SNPs selection using two-stage quality-based Random Forests. BMC Genomics (2015) 0.82
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron (2011) 18.73
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Genotype, haplotype and copy-number variation in worldwide human populations. Nature (2008) 12.40
A survey of genetic human cortical gene expression. Nat Genet (2007) 12.04
TREM2 variants in Alzheimer's disease. N Engl J Med (2012) 11.35
Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet (2009) 10.34
Genomewide association studies and human disease. N Engl J Med (2009) 9.05
Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron (2010) 7.87
Genotype-imputation accuracy across worldwide human populations. Am J Hum Genet (2009) 7.28
Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol Dis (2006) 5.96
A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet (2005) 5.81
New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58
Genome-wide SNP assay reveals structural genomic variation, extended homozygosity and cell-line induced alterations in normal individuals. Hum Mol Genet (2006) 5.50
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet (2012) 4.87
A genome-wide association study identifies protein quantitative trait loci (pQTLs). PLoS Genet (2008) 4.75
Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet (2008) 4.69
Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet (2010) 4.51
Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet (2012) 4.27
Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study. Lancet Neurol (2010) 4.19
Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons. J Neurosci (2003) 4.06
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain (2009) 4.01
Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol (2007) 3.93
Rotenone, paraquat, and Parkinson's disease. Environ Health Perspect (2011) 3.87
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet (2010) 3.86
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement. JAMA Neurol (2013) 3.70
Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet (2005) 3.63
Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Ann Neurol (2009) 3.62
Genetics of Parkinson's disease and parkinsonism. Ann Neurol (2006) 3.60
SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol (2009) 3.55
Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet (2009) 3.42
Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet (2011) 3.40
Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study. PLoS Genet (2009) 3.38
Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol (2004) 3.37
Genetic control of human brain transcript expression in Alzheimer disease. Am J Hum Genet (2009) 3.35
Chromosome 9 ALS and FTD locus is probably derived from a single founder. Neurobiol Aging (2011) 3.27
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. J Neurosci (2002) 3.12
DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA. Lancet Neurol (2008) 3.03
A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release. Lancet Neurol (2007) 2.99
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet (2011) 2.97
A closer look at unilateral versus bilateral deep brain stimulation: results of the National Institutes of Health COMPARE cohort. J Neurosurg (2010) 2.94
Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet (2013) 2.92
Solvent exposures and Parkinson disease risk in twins. Ann Neurol (2011) 2.92
Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet (2010) 2.76
RNA binding activity of the recessive parkinsonism protein DJ-1 supports involvement in multiple cellular pathways. Proc Natl Acad Sci U S A (2008) 2.76
Familial frontotemporal dementia with amyotrophic lateral sclerosis and a shared haplotype on chromosome 9p. J Neurol (2010) 2.75
CUBN is a gene locus for albuminuria. J Am Soc Nephrol (2011) 2.70
Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch Neurol (2005) 2.68
Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol (2010) 2.64